Interestingly, COMMD3 was significantly associated with markers of luminal differentiation and/or fate commitment in the luminal A-like tumours: tubule formation, androgen receptor (AR) [40], ELF5 [41] and cKIT [42] (Fig-2I). Here, COMMD3 is linked to neoplasm.